JNJ
Another courtroom bruise
Johnson & Johnson just got hit with a $10 million jury verdict in Louisiana over a mesothelioma case tied to talc exposure. The lawsuit was brought on behalf of the family of Lynne Roy, who died in 2020 after decades of exposure to talc products.
Why this matters for your portfolio
This isn’t just legal trivia. Talc litigation has been one of the most annoying recurring plotlines in the J&J saga, and every new verdict reminds investors that the story is far from over. Even when the dollar amount isn’t company-wrecking on its own, it adds pressure around future settlements, appeals, and headline risk.
The bigger headache
The company has spent years trying to box this issue in, but jury verdicts like this keep the saga on the scoreboard. That can matter for valuation because investors hate uncertainty almost as much as they hate surprise conference calls.
Big picture: one verdict doesn’t define J&J, but it does keep the talc drama firmly in the “still not resolved” bucket.